Fed. Circ. Won't Touch Hypertension Drug Producer's Loss
The Federal Circuit declined Thursday to second-guess a patent ruling out of Delaware federal court that ended a drugmaker's control over the market for liquid versions of its hypertension drug Epaned...To view the full article, register now.
Already a subscriber? Click here to view full article